Functional Technologies Corp.
TSX VENTURE : FEB

Functional Technologies Corp.

February 27, 2012 07:00 ET

Functional Technologies Reports Positive Data with Acrylamide-Preventing Yeasts in Mixtures for Commercial Extruded Starchy Food Products

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Feb. 27, 2012) - Functional Technologies Corp. (TSX VENTURE:FEB) (the "Company") reports that efficacy studies conducted on end-user materials, investigating the Company's proprietary acrylamide-preventing (AP) yeast technology in a novel food application that traditionally does not incorporate yeast ingredients as processing aids, have demonstrated significant reduction of asparagine, the main known precursor in the formation of acrylamide. Moreover, the reduction was achieved with short contact times and decreasing yeast dose concentrations. Acrylamide is a chemical shown to be a mutagen (i.e. carcinogenic), as well as neurologically and reproductively toxic. Functional Technologies previously demonstrated that the ability of its technology to reduce asparagine has been significantly effective in preventing the formation of, and thereby reducing, acrylamide.

Under the simulated commercial conditions defined by the industry third party, the use of Functional Technologies' AP yeast enabled substantial degradation and reduction of asparagine, which was achieved consistently and in a time-efficient manner utilizing conservative inoculation rates, including at relatively low AP yeast concentrations.

At a reduced dose between standard and lowest AP yeast concentrations, asparagine levels were decreased by approximately 85% within 30 minutes, and to near non-detectable levels within 60 minutes. At the lowest dose tested, reductions of 55% and 85% within 30 and 60 minutes, respectively, were observed. In head-to-head comparisons between the Company's AP yeast technology against samples with control or no yeast, which did not show any asparagine reduction in the allotted time period, these results clearly indicated that the AP yeast provided excellent performance in its functionality for acrylamide reduction and prevention.

These results support the claims that relevant processing protocols across a variety of food applications and sectors, including those that do not conventionally employ baker's yeasts as processing aids, have strong indications for the ability to implement and benefit from Functional Technologies' novel AP yeast technologies while minimizing any requirements for changes to existing production protocols, providing the potential for reasonably seamless adoption.

"Our collaborative efforts with leading companies across a variety of food sectors continue to provide us with compelling results like those reported today. These help to substantiate the effectiveness of Functional Technologies' proprietary yeast technologies in preventing and reducing acrylamide in an increasingly widening range of commercial food applications, including those that do not traditionally use baker's yeast," said Howard Louie, Functional Technologies' Executive Chairman and Chief Business Development Officer. "Such collaborations and studies facilitate the efficient optimization of our technology in a range of commercial materials and protocols, increasing awareness and appeal to interested global partners and monitoring agencies, while providing commercial pathways by which to advance and expand on our platform-based technologies."

About Functional Technologies Corp.

Functional Technologies develops and commercializes proprietary, advanced yeast-based solutions to significant challenges in the food, beverage and healthcare industries. The Company's platform improves the performance of innate yeast functions, and prevents the formation of naturally occurring toxins and contaminants that either affect final product quality or are classified by the World Health Organization as probable human carcinogens. Functional Technologies' lead technologies include yeasts that prevent and reduce the formation of the foul-smelling hydrogen sulphide (H2S) and the carcinogens acrylamide and ethyl carbamate (more commonly known as urethane), by-products of food and beverage processing. These contaminants are found in many commonly consumed items, such as fermented food products and alcoholic beverages, and baked and fried foods. With a head office in Vancouver, Functional Technologies Corp. has R&D operations in Prince Edward Island and Europe, as well as a U.S. sales office in Napa Valley, California. For more information, please visit our website at www.functionaltechcorp.com.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information